title: Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome.
authors.forename: Yuriko
authors.initials: Y
authors.lastname: Yahata
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Isobe
authors.forename: Makoto
authors.initials: M
authors.lastname: Sasaki
authors.forename: Kazuo
authors.initials: K
authors.lastname: Oshimi
authors.forename: Koichi
authors.initials: K
authors.lastname: Sugimoto
mesh_terms: D000910:Antibodies, Heterophile / Q000097:blood; D000961:Antilymphocyte Serum / Q000494:pharmacology* / Q000627:therapeutic use; D005189:False Positive Reactions; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D007118:Immunoassay / Q000592:standards; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000910:Antibodies, Heterophile; D000961:Antilymphocyte Serum; D005338:Fibrin Fibrinogen Degradation Products